Harvard Bioscience (HBIO) Amortizatization of Intangibles (2010 - 2026)
Harvard Bioscience (HBIO) reported Amortizatization of Intangibles of $907000.0 for Q1 2026, down 24.67% year-over-year from $1.2 million in Q1 2025, and up 1.45% quarter-over-quarter from $894000.0 in Q4 2025.
Harvard Bioscience (HBIO) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Amortizatization of Intangibles data on file, last reported at $907000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $907000.0, down 24.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 25.72% YoY), and the FY2025 annual result was $4.2 million, down 22.62% from the prior year.
- Amortizatization of Intangibles grew to $907000.0 in Q1 2026 per HBIO's latest filing, from $894000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.6 million in Q4 2022 and troughed at $894000.0 in Q4 2025.
- A 5-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles climbed 12.26% in 2022, then tumbled 34.76% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.6 million in 2022, then fell by 14.91% to $1.4 million in 2023, then slipped by 6.2% to $1.3 million in 2024, then tumbled by 31.28% to $894000.0 in 2025, then advanced by 1.45% to $907000.0 in 2026.
- Business Quant data shows HBIO's Amortizatization of Intangibles at $907000.0 in Q1 2026, $894000.0 in Q4 2025, and $899000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 10.20 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 10.05 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 600,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 10.06 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 907,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 907,000.00 |
| Mar 31, 2026 | 907,000.00 |
| Dec 31, 2025 | 894,000.00 |
| Dec 31, 2025 | 894,000.00 |
| Sep 30, 2025 | 899,000.00 |
| Sep 30, 2025 | 899,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Dec 31, 2023 | 1.39 Mn |